Published on 10 Apr 2024 on Simply Wall St. via Yahoo Finance
Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like they did in the case of Cyclo Therapeutics, Inc. (NASDAQ:CYTH), that sends out a positive message to the company's shareholders.
While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, we do think it is perfectly logical to keep tabs on what insiders are doing.
View our latest analysis for Cyclo Therapeutics